HSP105 Polyclonal Antibody

Rabbit Anti-HSP105 Polyclonal Antibody

Product Specifications

Background

HSPH1 is a Protein Coding gene. Heat shock protein 105 kDa prevents the aggregation of denatured proteins in cells under severe stress, on which the ATP levels decrease markedly. Inhibits HSPA8/HSC70 ATPase and chaperone activities Diseases associated with HSPH1 include hepatitis d. Among its related pathways are Cellular response to heat stress and Cellular Senescence. Gene Ontology (GO) annotations related to this gene include alpha-tubulin binding. An important paralog of this gene is HSPA4L.

CAS Number

9007-83-4

Product Name Alternative

HSPH1; HSP105; HSP110; KIAA0201; Heat shock protein 105 kDa; Antigen NY-CO-25; Heat shock 110 kDa protein

Gene ID

10808

Accession Number

Q92598

Reactivity

Human, Mouse

Immunogen

Synthesized peptide derived from the C-terminal region of human HSP105 at AA range: 760-840

Clonality

Polyclonal

Tag

Heat shock protein 105 kDa

Applications

WB, IHC, IF, ELISA

Purification Method

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.

Concentration

1 mg/ml

Molecular Weight

100kD

Precautions

The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Shipping Conditions

Gel pack with blue ice.

Storage Conditions

Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Notes

HSP105 Polyclonal Antibody detects endogenous levels of HSP105 protein.

Observed Molecular Weight

100

Formulation

Liquid solution

Buffer pH

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Applications Notes

Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000; IHC 1:100-1:300; IF 1:200-1:1000; ELISA 1:10000; Not yet tested in other applications.